How much is Teligent stock worth?
Apr 23, 2022 · Delisting of Securities of Teligent, Inc. from The Nasdaq Stock Market - GlobeNewswire. globenewswire.com - October 27 at 1:19 AM. Firm Retention Summary: Teligent Inc. - The Wall Street Journal. wsj.com - October 20 at 8:24 PM. Generic drugmaker Teligent approved to tap bankruptcy loan - Reuters.
Who bought tlgt stock?
Apr 21, 2022 · Teligent, Inc. NASDAQ Updated Apr 21, 2022 3:03 PM TLGT 0.00 0.00 (0.00%). 8,328
What does Teligent do?
Nov 07, 2017 · Shares of specialty generic pharmaceutical manufacturer Teligent (NASDAQ: TLGT) dropped as much as 46% today after investors digested the company's third-quarter 2017 results. Operations appeared...
What happened to Teligent Inc?
Teligent, of Buena in Atlantic County, filed for U.S. Bankruptcy Court protection with assets of $89 million and debts of $135.8 million. In mid-January, Teligent entered into an agreement to sell its Canadian assets to Hikma, a London-based generic drug company, for $47.5 million.Feb 28, 2022
What is going on with Teligent?
Teligent, which had been struggling financially and was under intense scrutiny by the FDA over manufacturing issues, declared bankruptcy last October. At the time, the company let go of 133 workers and said it would begin selling off its assets.Jan 18, 2022
Why is Teligent stock so low?
The company had to lower prices to keep pace with the competition, which cut into gross margin. It also lowered its full-year 2017 revenue guidance to $65 million to $67 million, down from the previous range of $75 million to $85 million as a result.Nov 7, 2017
What is Teligent?
A Topical and Injectable Pharmaceutical Company We market a growing portfolio of FDA-approved medicines, including several generic alternatives, in the United States. Our products include both injectable and topical prescription medicines. Learn more about: Our Products.
Who is buying Teligent?
drugmaker Hikma PharmaceuticalsLondon-listed Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) has agreed to acquire the Canadian assets of Teligent for $45.75 million.Jan 17, 2022
Will Teligent be delisted?
Teligent's shares of common stock are scheduled for delisting at the opening of business on October 18, 2021, and may thereafter trade in the over-the-counter market.Oct 14, 2021
What is Teligent Incorporated?
Teligent, Inc. manufactures and distributes pharmaceutical products. The Company offers creams, ointments, injections, and other medical products. Teligent markets its products in the United States.Oct 14, 2021
Teligent Media Sentiment
Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.
Media Coverage
We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.
Teligent (NASDAQ TLGT) News Headlines Today
Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm.
Third-quarter 2017 results show the company's high-growth business model is not without risks
Maxx has been a contributor to Fool.com since 2013. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering.
What happened
Shares of specialty generic pharmaceutical manufacturer Teligent ( NASDAQ:TLGT) dropped as much as 46% today after investors digested the company's third-quarter 2017 results. Operations appeared to have slowed after a strong first half of the year. That forced management to lower its full-year 2017 financial guidance for revenue and gross margin.
So what
The primary investment thesis for Teligent is that it has the potential to be at least a moderate growth stock for years to come.
Now what
A haircut of over 40% is a pretty extreme reaction by investors. Is it warranted? Well, the high-growth potential of Teligent seems to be open to criticism after the performance in the most recent quarter.
What stocks does MarketBeat like better than Teligent?
Wall Street analysts have given Teligent a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Teligent wasn't one of them.
Are investors shorting Teligent?
Teligent saw a increase in short interest during the month of August. As of August 13th, there was short interest totaling 2,210,000 shares, an increase of 339.4% from the July 29th total of 503,000 shares. Based on an average trading volume of 2,650,000 shares, the days-to-cover ratio is presently 0.8 days.
When is Teligent's next earnings date?
Teligent is scheduled to release its next quarterly earnings announcement on Thursday, December 30th 2021.#N#View our earnings forecast for Teligent.
How were Teligent's earnings last quarter?
Teligent, Inc. (NASDAQ:TLGT) released its quarterly earnings results on Monday, August, 16th. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.13) by $0.01.#N#View Teligent's earnings history.
How has Teligent's stock price been impacted by Coronavirus (COVID-19)?
Teligent's stock was trading at $3.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TLGT stock has decreased by 87.2% and is now trading at $0.4168.#N#View which stocks have been most impacted by COVID-19.
When did Teligent's stock split? How did Teligent's stock split work?
Teligent shares reverse split on the morning of Thursday, May 28th 2020. The 1-10 reverse split was announced on Wednesday, May 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 27th 2020.
What is Tim Sawyer's approval rating as Teligent's CEO?
2 employees have rated Teligent CEO Tim Sawyer on Glassdoor.com. Tim Sawyer has an approval rating of 100% among Teligent's employees. This puts Tim Sawyer in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.
What happened
Shares of specialty generic pharmaceutical manufacturer Teligent (NASDAQ: TLGT) dropped as much as 46% today after investors digested the company's third-quarter 2017 results. Operations appeared to have slowed after a strong first half of the year. That forced management to lower its full-year 2017 financial guidance for revenue and gross margin.
So what
The primary investment thesis for Teligent is that it has the potential to be at least a moderate growth stock for years to come.
Now what
A haircut of over 40% is a pretty extreme reaction by investors. Is it warranted? Well, the high-growth potential of Teligent seems to be open to criticism after the performance in the most recent quarter.
The Motley Fool
Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community.
Component Grades
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
TLGT POWR Grades
TLGT scores best on the Value dimension, with a Value rank ahead of 75.1% of US stocks.
TLGT Stock Summary
Teligent Inc's market capitalization of $36,198,822 is ahead of merely 3.52% of US-listed equities.
TLGT Valuation Summary
TLGT's price/earnings ratio is -0.4; this is 101.1% lower than that of the median Healthcare stock.
TLGT Growth Metrics
For more insight on analysts targets of TLGT, see our TLGT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Latest TLGT News From Around the Web
Below are the latest news stories about Teligent Inc that investors may wish to consider to help them evaluate TLGT as an investment opportunity.
Continue Researching TLGT
Want to see what other sources are saying about Teligent Inc's financials and stock price? Try the links below: